The safety and efficacy of doses higher than 0.5 mg/day of dutasteride in male androgenic alopecia.
Fernández Esparcia PJ, Saceda-Corralo D, Jiménez-Cahue J, Gil-Redondo R, Buendía-Castaño D, Imbernón-Moya A, Vañó-Gaván S, Hermosa-Gelbard Á
Journal of the European Academy of Dermatology and VenereologyIn the feed 29 Sep 2026, published online 29 Sep 2026, issue 2026 Sep 29, added to PubMed 29 Sep 2026
Topics: Hair
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42808698 · DOI 10.1111/jdv.70780